evolcSign inStart free
Menu

Zelluna

Clinical-stage biotech developing TCR-guided NK cell therapies for solid cancers, led by ZI-MA4-1 in a Phase 1 trial

Oslo, NorwayFounded 2011zelluna.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-29

About Zelluna

Zelluna develops T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK, for solid cancers. Its lead candidate, ZI-MA4-1, is in the Phase 1 ZIMA-101 trial in the UK, and the company reported dosing its first patient in 2026. The platform combines TCR guidance with the effector functions of allogeneic NK cells, which the company describes as an off-the-shelf approach.

The therapies target patients with solid cancers, which the company describes as the largest unmet need in cancer treatment, in high value markets.

Zelluna ASA was founded in 2011 and is headquartered at the Oslo Cancer Cluster Innovation Park in Oslo, Norway. Its predecessor, Zelluna Immunotherapy AS, was established in 2016. In March 2025 Zelluna Immunotherapy AS combined its business with Ultimovacs ASA to form Zelluna. The company is listed on the Oslo Stock Exchange under the ticker ZLNA.

Product: TCR-NK cell therapy platform; lead candidate ZI-MA4-1 in the Phase 1 ZIMA-101 trial for solid cancers.

Jobs at Zelluna

No open positions listed right now.

More biotech & pharma companies

  • Zenit Science

    Life science research and contract services for drug developers and researchers working on serious diseases
    Trondheim, NorwayBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • Age Labs

    Biomarker discovery and epigenetic analysis for pharmaceutical, nutraceutical and clinical research customers
    Oslo, NorwayBiotech & pharmaFounded 2017
    New on Evolc

  • Agilera Pharma

    Radiopharmaceutical CDMO in Norway, handling development to commercial supply for drug developers and research groups
    Kjeller, NorwayBiotech & pharmaFounded 20211 open job
    Young companyNew on Evolc

  • Alginor

    Harvests and biorefines Norwegian kelp into formaldehyde-free ingredients for pharma and nutraceutical manufacturers
    Avaldsnes, NorwayBiotech & pharmaFounded 2014
    New on Evolc

  • Algipharma

    Develops alginate-based drug delivery technologies and therapeutics for pharmaceutical and healthcare applications
    Sandvika, NorwayBiotech & pharmaFounded 1992
    New on Evolc

  • Amicoat

    Antimicrobial peptide coating technology for medical device makers aiming to reduce hospital-acquired infections
    Asker, NorwayBiotech & pharmaFounded 2014
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google Tag Manager
  • WordPress
  • jQuery
  • nginx